| Insider | Venker Eric |
|---|---|
| Title | President & Immunovant CEO |
| Transaction Date | Feb 13, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Shares |
| Direct/Indirect | Direct |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 13, 2026 |
| Shares Sold | 200,000 |
| Price per Share | $26.49 |
| Total Value | $5,298,000.00 |
| Shares Owned After | 1,654,597 |
| Derivative | No |
| Accession Number | 0001635088-26-000017 |
| Document | View SEC Filing |